Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer.

Autor: Agostini, Antonio1,2 (AUTHOR), Guerriero, Ilaria3 (AUTHOR), Piro, Geny1,2 (AUTHOR) geny.piro@policlinicogemelli.it, Quero, Giuseppe4 (AUTHOR), Roberto, Luca3 (AUTHOR), Esposito, Annachiara1,2 (AUTHOR), Caggiano, Alessia1,2 (AUTHOR), Priori, Lorenzo1,2 (AUTHOR), Scaglione, Giulia5 (AUTHOR), De Sanctis, Francesco6 (AUTHOR), Sistigu, Antonella7 (AUTHOR), Musella, Martina7 (AUTHOR), Larghi, Alberto8,9 (AUTHOR), Rizzatti, Gianenrico8,9 (AUTHOR), Lucchetti, Donatella10,11 (AUTHOR), Alfieri, Sergio4 (AUTHOR), Sgambato, Alessandro10,11 (AUTHOR), Bria, Emilio1,2 (AUTHOR), Bizzozero, Laura12,13 (AUTHOR), Arena, Sabrina12,13 (AUTHOR)
Zdroj: Journal of Translational Medicine. 11/23/2023, Vol. 21 Issue 1, p1-15. 15p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje